American scientists have developed a unique vaccine that helps protect the body from any respiratory viral diseases.
Experts from Emory University in Georgia on the eve has published the results of preliminary testing of the vaccine. According to the obtained data, the drug prevents the development of colds after contact with the virus in the human body in 88% of cases. The introduction of drugs, the researchers say, is able to protect from colds in 49 cases out of 50.
As soon as the drug enters the bloodstream, it immediately starts the process of formation of antibodies to viral diseases. As a result, the body develops protection against most respiratory infections.
Similar effect, scientists tried to achieve for several decades. Attempts, begun in the 70-ies, was not successful. Now the problem of colds, experts say, is practically solved. It only remains to make the vaccine available to all.